Europe

AstraZeneca’s Imfinzi-Lynparza Combo Wins Landmark EU Nod for Endometrial Cancer
BioSpace
Wed, 08/14/24 - 10:58 am
AstraZeneca
Europe
Imfinzi
Lynparza
endometrial cancer
After EU setback, Eisai/Biogen build case for Leqembi
Pharmaphorum
Wed, 07/31/24 - 10:25 am
Eisai
Biogen
Alzheimer's disease
Leqembi
Europe
Eisai 'extremely disappointed' by EMA's decision on Alzheimer's drug
Biopharma Reporter
Tue, 07/30/24 - 11:37 am
Eisai
EMA
Europe
Leqembi
Biogen
Alzheimer's disease
AbbVie’s Skyrizi Wins EU Nod for Ulcerative Colitis, Helps to Weather Humira Patent Cliff
BioSpace
Mon, 07/29/24 - 10:31 am
AbbVie
Europe
Skyrizi
ulcerative colitis
Eisai and Biogen's Alzheimer's med Leqembi turned down in Europe
Fierce Pharma
Fri, 07/26/24 - 11:15 am
Eisai
Biogen
Leqembi
Europe
Pfizer quickly expands its hemophilia B gene therapy's reach with EU approval
Fierce Pharma
Thu, 07/25/24 - 10:02 pm
Pfizer
hemophila B
Beqvez
Durveqtix
Europe
GSK plots Blenrep's plot back to market with EU filing
BioSpace
Mon, 07/22/24 - 11:33 am
GSK
Blenrep
relaunch
Multiple Myeloma
Europe
Sanofi and Regeneron's Dupixent scores in Europe as the first biologic to treat COPD
Fierce Pharma
Wed, 07/3/24 - 11:26 am
Sanofi
Regeneron
Europe
COPD
Dupixent
Dupixent nears EU approval for COPD, as FDA delays
Pharmaphorum
Fri, 05/31/24 - 10:49 am
Sanofi
Regeneron
Dupixent
COPD
EMA
Europe
FDA
European Commission grants marketing approval to Biogen's ALS drug
Reuters
Thu, 05/30/24 - 11:05 pm
Biogen
Europe
Ionis Pharmaceuticals
ALS
Qalsody
3rd time's the charm? PTC will get another chance to keep Translarna's European marketing authorization
Fierce Pharma
Mon, 05/20/24 - 05:46 pm
PTC Therapeutics
Translarna
Europe
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters
Sun, 05/19/24 - 10:48 pm
Moderna Therapeutics
Europe
Pfizer
BioNTech
patents
COVID-19
European Commission approves Astellas’ drug for expanded prostate cancer Treatment
Outsourcing Pharma
Thu, 04/25/24 - 05:59 pm
Astellas
Xtandi
Europe
prostate cancer
EU approves Illumina's plan to divest cancer test maker Grail
Reuters
Fri, 04/12/24 - 11:08 am
Europe
Illumina
Grail
M&A
diagnostics
Medtech
EMA to Review Diabetes and Weight-Loss Drugs for Suicidal Ideation Risk
BioSpace
Tue, 04/9/24 - 11:11 am
EMA
Europe
diabetes
weight loss
Novo Nordisk
Ozempic
Wegovy
Eli Lilly
Trulicity
Saxenda
Rybelsus
Victoza
EU Approves Merck’s Keytruda, Chemo Combo for Lung Cancer
BioSpace
Thu, 03/28/24 - 04:56 pm
Merck
Europe
Keytruda
non-small cell lung cancer
89bio wins EMA priority status for MASH candidate pegozafermin
Clinical Trials Arena
Thu, 03/28/24 - 11:21 am
89Bio
Europe
EMA
pegozafermin
MASH
European study finds popular ALS drug ineffective
BioPharma Dive
Wed, 03/27/24 - 10:31 pm
Amylyx
TUDCA
ALS
clinical trials
Europe
Eisai and Biogen facing delay to Leqembi in Europe
Pharmaphorum
Mon, 03/25/24 - 11:22 am
Eisai
Biogen
Leqembi
Europe
Alzheimer's disease
EU adviser says Illumina merger was not problematic
Stat
Fri, 03/22/24 - 09:33 am
Illumina
Grail
M&A
Europe

Pages